Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Antibiotic efflux mechanisms.

H Nikaido1, H I Zgurskaya

  • 1Department of Molecular and Cell Biology, University of California, Berkeley, California 94720-3206, USA. nhiroshi@uclink4.berkeley.edu

Current Opinion in Infectious Diseases
|October 13, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The role of outer membrane and efflux pumps in the resistance of gram-negative bacteria. Can we improve drug access?

Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy·2006
Same author

Mechanistic parallels in bacterial and human multidrug efflux transporters.

Current protein & peptide science·2002
Same author

Lipid-layer crystallization and preliminary three-dimensional structural analysis of AcrA, the periplasmic component of a bacterial multidrug efflux pump.

Journal of structural biology·2002
Same author

Functional relevance of carnitine transporter OCTN2 to brain distribution of L-carnitine and acetyl-L-carnitine across the blood-brain barrier.

Journal of neurochemistry·2001
Same author

Management of pregnancy with congenital antithrombin III deficiency: two case reports and a review of the literature.

The journal of obstetrics and gynaecology research·2001
Same author

A MATE family multidrug efflux transporter pumps out fluoroquinolones in Bacteroides thetaiotaomicron.

Antimicrobial agents and chemotherapy·2001

Multidrug efflux pumps are common in microorganisms and a major cause of drug resistance. Overexpression or acquisition of these pumps leads to significant resistance, impacting treatment outcomes.

Area of Science:

  • Microbiology
  • Molecular Biology
  • Pharmacology

Background:

  • Multidrug efflux pumps are widespread in bacterial and yeast genomes.
  • These pumps contribute significantly to intrinsic drug resistance, especially in low-permeability cell wall organisms like Gram-negative bacteria and Mycobacteria.
  • Overproduction or acquisition of efflux pump genes elevates drug resistance levels.

Purpose of the Study:

  • To review the classification and mechanisms of multidrug efflux proteins.
  • To discuss the regulation of multidrug efflux pump gene expression.
  • To highlight the clinical significance of multidrug efflux pumps in antimicrobial resistance.

Main Methods:

  • Literature review of existing research on multidrug efflux pumps.
  • Analysis of genomic data for efflux pump gene prevalence.

Related Experiment Videos

  • Discussion of biochemical and genetic mechanisms of efflux.

    • Main Results:

    • Efflux pumps are classified based on their structure and function.
    • Mechanisms involve active transport of drugs out of the cell.
    • Regulation of expression varies, influencing resistance levels.

    Conclusions:

    • Multidrug efflux is a critical factor in microbial drug resistance.
    • Understanding efflux pump mechanisms and regulation is vital for developing strategies to combat resistance.
    • Efflux pumps represent significant targets for antimicrobial drug development.